Synergy with interferon-lambda 3 and sorafenib suppresses hepatocellular carcinoma proliferation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Synergy with interferon-lambda 3 and sorafenib suppresses hepatocellular carcinoma proliferation

Published:2017-04 Issue: Volume:88 Page:395-402
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Yan Yuke,Wang Liang,He Jingjing,Liu Pengcheng,Lv Xi,Zhang Yawu,Xu Xiaodong,Zhang Lingyi,Zhang Youcheng

Funder

Gansu Provincial-level Key Laboratory of Digestive System Tumors

Natural Science Foundation of Gansu Province

Science and Technology Projects of Lanzhou City

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference32 articles.

1. Global cancer statistics;Jemal;CA Cancer J. Clin.,2011

2. Hepatitis B-related hepatocellular carcinoma: epidemiological characteristics and disease burden;Nguyen;J. Viral Hepat.,2009

3. Epidemiology of viral hepatitis and hepatocellular carcinoma;El-Serag;Gastroenterology,2012

4. Concurrent versus sequential sorafenib therapy in combination with radiation for hepatocellular carcinoma;Wild;PLoS One,2013

5. The role of signaling pathways in the development and treatment of hepatocellular carcinoma;Whittaker;Oncogene,2010

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of switch therapy to tenofovir versus entecavir maintenance on recurrence of hepatocellular carcinoma after surgery (SWITE): study protocol for a randomized controlled trial;Trials;2023-12-02

2. Therapeutic efficacy of sorafenib and plant-derived phytochemicals in human colorectal cancer cells;BMC Complementary Medicine and Therapies;2023-06-26

3. Neoadjuvant and Adjuvant Systemic Therapies in Loco-Regional Treatments for Hepatocellular Carcinoma: Are We at the Dawn of a New Era?;Cancers;2023-05-27

4. Predictors of early and late hepatocellular carcinoma recurrence;World Journal of Gastroenterology;2023-02-28

5. The E3 ligase subunit FBXO45 binds the interferon-λ receptor and promotes its degradation during influenza virus infection;Journal of Biological Chemistry;2022-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3